New Frontier Health/United Family Healthcare Strengthens Strategic Partnership with Warburg Pincus to Reinforce Leadership in China's Premium Private Healthcare Sector

Recently, New Frontier Health/United Family Healthcare (UFH), a benchmark enterprise for high-end private medical services in China, announced the deepening of its strategic cooperation with Warburg Pincus, a global leader in private equity investment, with the latter further increasing its equity stake in UFH. This upgraded partnership underscores Warburg Pincus’s confidence in UFH’s development strategy and will further help UFH solidify its leading position in China’s private healthcare industry. Upon completion of the transaction, Warburg Pincus will become a significant shareholder of UFH and secure a seat on the Board of Directors.

United Family Healthcare (UFH), a subsidiary of New Frontier Health Corporation, a leading private healthcare service platform in China, is committed to delivering high-quality, patient-centered medical services. The UFH network comprises 11 hospitals and 24 clinics across Beijing, Shanghai, Hong Kong, Guangzhou, Shenzhen, Tianjin, and Qingdao, serving over one million patient visits annually. By offering interdisciplinary, full-lifecycle healthcare services, upheld by rigorous quality standards, meticulous care, the application of innovative pharmaceuticals and medical devices, and diverse payment options, UFH has become the preferred one-stop healthcare provider for China’s high-net-worth individuals.

Wu Qinan, Co-Founder and CEO of New Frontier Health Corporation, and CEO of United Family HealthcareWarburg Pincus stated: “This increased investment by Warburg Pincus demonstrates strong recognition of United Family Healthcare’s development. Its global perspective and expertise in the healthcare industry will inject critical momentum into United Family Healthcare’s growth. We are confident in continuing to fulfill our mission of enhancing access to high-quality medical services and innovative pharmaceuticals and medical devices in China.”

Fang Min, Partner and Co-President of Private Equity Investment in China at Warburg PincusWarburg Investment stated: “We highly recognize United Family Healthcare’s unique advantages and the achievements it has made in recent years. We are pleased to have increased our stake in United Family Healthcare, and we will continue to support the company’s development, striving to create long-term value for patients through continuous innovation.”

It is worth noting that in February this year, New Frontier Group, the parent company of New Frontier Health/United Family Healthcare (UFH), entered into a strategic partnership with Hong Kong Investment Corporation Ltd. (“HKIC”), marking HKIC’s first announced investment project of 2025. Moving forward, New Frontier Health/UFH will prioritize strategic initiatives that underpin long-term growth, including deepening its presence in the Beijing-Tianjin region, Shanghai, and the Greater Bay Area to expand service scale and clinical capabilities, while building a multi-campus, multi-tiered healthcare ecosystem; completing its research transformation and tackling key disciplinary challenges by designating oncology as a priority specialty and comprehensively enhancing clinical research capabilities; advancing technological and digital innovation by fully leveraging rich medical data to drive artificial intelligence and digital health projects; and strengthening global partnerships to reinforce its role as China’s leading international healthcare provider, thereby promoting bidirectional medical treatment and collaboration between China and the rest of the world.